UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055218
Receipt number R000062735
Scientific Title A study of ultrasound probe processing methods in the emergency department: a single-centre, single-blind, randomized, controlled trial
Date of disclosure of the study information 2024/08/12
Last modified on 2024/10/31 14:00:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of ultrasound probe processing methods in the emergency department: a single-centre, single-blind, randomized, controlled trial

Acronym

Trophon study

Scientific Title

A study of ultrasound probe processing methods in the emergency department: a single-centre, single-blind, randomized, controlled trial

Scientific Title:Acronym

Trophon study

Region

Japan


Condition

Condition

Any emergency diseases

Classification by specialty

Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to determine whether treatment of probes that have been used on or contaminated by patients with a reprocessing flow using the Nanosonics trophon2 ultrasound probe cleaner/disinfector (hereinafter trophon2) can reduce contamination immediately before patient use.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Ultrasonic probe contamination rate (bacterial detection rate, bacterial colony count)

Key secondary outcomes

bacterial species
Sample collection time


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

<trophon2 group>
Remove the ultrasonic probe from the ultrasonic device, reprocess it using trophon2, attach the probe cover after reprocessing, and connect it to the ultrasonic device. If the probe cover comes off unintentionally, reprocess the probe using trophon2 again and reattach the probe cover after reprocessing.

Interventions/Control_2

<Standard wiping group>
The subject ultrasound probe should be wiped with a dry wipe or a wet towel moistened with water while still connected to the ultrasound machine. Additional wiping with ethanol wipes may be added at the discretion of the physician who used the machine.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

ultrasound probe used on a patient in the emergency room or equally contaminated

Key exclusion criteria

Probe deemed inappropriate for inclusion in the study by the physician who used it

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Junichi
Middle name
Last name Sasaki

Organization

Keio University School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN

TEL

0332251323

Email

sasaki.junichi@z8.keio.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Yamamoto

Organization

Keio University School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN

TEL

0332251323

Homepage URL


Email

ryoyamamoto@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Nanosonics Japan K.K.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine, Institutional Review Board

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN

Tel

0333531211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 08 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 06 Month 03 Day

Date of IRB

2024 Year 06 Month 03 Day

Anticipated trial start date

2024 Year 08 Month 18 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 08 Month 11 Day

Last modified on

2024 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062735